Ultrastructural Study on Colocalization of Glucagon-Like Peptide (GLP)-1 with GLP-2 in Chicken Intestinal L-Cells

被引:27
|
作者
Nishimura, Kei [1 ]
Hiramatsu, Kohzy [2 ]
Monir, Mohammad M. [3 ]
Takemoto, Chihiro [1 ]
Watanabe, Takafumi [2 ]
机构
[1] Shinshu Univ, Grad Sch Agr, Dept Food Prod Sci, Kami, Nagano 3994598, Japan
[2] Shinshu Univ, Fac Agr, Lab Anim Funct Anat, Kami, Nagano 3994598, Japan
[3] Shinshu Univ, Interdisciplinary Grad Sch Sci & Technol, Dept Biosci & Food Prod Sci, Kami, Nagano 3994598, Japan
来源
JOURNAL OF VETERINARY MEDICAL SCIENCE | 2013年 / 75卷 / 10期
关键词
chicken; glucagon-like peptides; immunocytochemistry; immunohistochemistry; small intestine; GASTROINTESTINAL-TRACT; HUMAN-COLON; FOOD-INTAKE; SECRETION; SOMATOSTATIN; PANCREAS; MOTILITY; INSULIN; LIGHT; RAT;
D O I
10.1292/jvms.13-0106
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Colocalization of glucagon-like peptide (GLP)-1 with GLP-2 in L-cells was investigated in the chicken ileum by using double immunofluorescent and immunocytochemical techniques. Ultrastructural features of L-cells were also clarified in this study. L-cells showing immunoreactivity for both GLP-1 and GLP-2 were distributed in the whole ileum. They showed comma-like or flask-like shape and were located in epithelium of crypts and lower part of intestinal villi. L-cells showing GLP-1-immunoreactivity only were found in epithelium of lower and middle parts of intestinal villi. Transmission electron microscopy indicated that L-cells identified by colloidal gold-labeled immunocytochemistry were covered apically with microvilli, open-type and contained many secretory granules in their perikarya. These secretory granules without halo were round to oval in shape and showed moderate electron density. The longest and shortest diameters of secretory granules were 355 +/- 62 nm (mean +/- SD) and 287 +/- 48 nm, respectively. Double labeling immunocytochemistry using two different sizes of particles (6 and 12 nm in diameter) of colloidal gold revealed that GLP-1 colocalized with GLP-2 in the same secretory granules. This study advances new morphological data about the endocrine system of the chicken small intestine.
引用
收藏
页码:1335 / 1339
页数:5
相关论文
共 50 条
  • [21] Structure, analysis and secretion of human glucagon-like peptide-2 (GLP-2)
    Hartmann, B
    Johnsen, AH
    Orskov, C
    Holst, JJ
    DIABETES, 1996, 45 : 1117 - 1117
  • [22] Naturally occurring glucagon-like peptide-2 (GLP-2) receptors in human intestinal cell lines
    Sams, A
    Hastrup, S
    Andersen, M
    Thim, L
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 532 (1-2) : 18 - 23
  • [23] Treatment of inflammatory bowel disease (IBD) with the intestinal growth factor glucagon-like peptide 2 (GLP-2)
    Alavi, K
    Prasad, R
    Palazzo, JP
    Schwartz, MZ
    PEDIATRICS, 1999, 104 (03) : 769 - 769
  • [24] Glucagon-like peptide-2 (GLP-2) modulates intestinal permeability in the parenterally fed neonatal gut
    Kansagra, K
    Stoll, B
    Rognerud, C
    Ou, CN
    Burrin, D
    PEDIATRIC RESEARCH, 2003, 53 (04) : 395A - 395A
  • [25] Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice
    Thulesen, J
    Hartmann, B
    Hare, KJ
    Kissow, H
    Orskov, C
    Holst, JJ
    Poulsen, SS
    GUT, 2004, 53 (08) : 1145 - 1150
  • [26] Glucagon-like peptide-2 (GLP-2) modulates intestinal permeability in the parenterally fed neonatal gut
    Kansagra, K
    Stoll, B
    Lu, XF
    Rognerud, C
    Ou, CN
    Burrin, D
    FASEB JOURNAL, 2003, 17 (04): : A305 - A305
  • [27] Inhibition of glucagon-like peptide (GLP-I) secretion from rat intestinal L-cells by somatostatin and galanin.
    HerrmannRinke, C
    Horsch, D
    Anronld, R
    Goke, B
    GASTROENTEROLOGY, 1996, 110 (04) : A1079 - A1079
  • [28] Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression
    Anthony P. Ramsanahie
    Urs V. Berger
    Michael J. Zinner
    Edward E. Whang
    David B. Rhoads
    Stanley W. Ashley
    Digestive Diseases and Sciences, 2004, 49 : 1731 - 1737
  • [29] Effect of glucagon-like peptide-2 (GLP-2) on diurnal SGLT1 expression
    Ramsanahie, AP
    Berger, UV
    Zinner, MJ
    Whang, EE
    Rhoads, DB
    Ashley, SW
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (11-12) : 1731 - 1737
  • [30] Glucagon-like peptide 1 (GLP-1)
    Mueller, T. D.
    Finan, B.
    Bloom, S. R.
    D'Alessio, D.
    Drucker, D. J.
    Flatt, P. R.
    Fritsche, A.
    Gribble, F.
    Grill, H. J.
    Habener, J. F.
    Holst, J. J.
    Langhans, W.
    Meier, J. J.
    Nauck, M. A.
    Perez-Tilve, D.
    Pocai, A.
    Reimann, F.
    Sandoval, D. A.
    Schwartz, T. W.
    Seeley, R. J.
    Stemmer, K.
    Tang-Christensen, M.
    Woods, S. C.
    DiMarchi, R. D.
    Tschoep, M. H.
    MOLECULAR METABOLISM, 2019, 30 : 72 - 130